Citations

Mayo Clinic

Showing 10 of 108585 citations.

Patient- versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study
Tveiten, Øystein Vesterli , Carlson, Matthew L. , Goplen, Frederik Kragerud , Myrseth, Erling , Driscoll, Colin L. W., Link, Michael J., Lund‐Johansen, Morten , Mahesparan, Rupavathana , Link, Michael J.

Journal of Neurosurgery | December 2, 2016 | Volume: 127 | Issue: 5 | Pages: 1015-1024

10.3171/2016.8.jns16707 | PMID 27911236 Get It

OBJECTIVEPatient-reported outcomes are increasingly used in studies of vestibular schwannoma (VS); however, few studies have examined self-evaluated facial nerve function and its relation to physician-reported outcomes. The primary objective of this study was to compare patient self-evaluations of facial disability with physician-evaluated facial nerve status and with self-evaluations of a healthy control group. The second objective was to provide insight into the controversial subject of the optimal initial management of small- and medium-sized VSs; consequently, the authors compared patient-reported facial nerve disability following treatment via observation (OBS), Gamma Knife surgery (GKS), or microsurgery (MS). Lastly, the authors sought to identify risk factors for facial nerve dysfunction following treatment for small- and medium-sized VSs.METHODSAll patients with a VS 3 cm or smaller that was singly treated with OBS, GKS, or MS at either of 2 independent treatment centers between 1998 and 2008 were retrospectively identified. Longitudinal facial nerve measures and clinical data, including facial nerve evaluation according to the House-Brackmann (HB) grading system, were extracted from existing VS databases. Supplementing the objective data were Facial Disability Index (FDI) scores, which were obtained via survey of patients a mean of 7.7 years after initial treatment.RESULTSThe response rate among the 682 eligible patients was 79%; thus, data from a total of 539 patients were analyzed. One hundred forty-eight patients had been managed by OBS, 247 with GKS, and 144 with MS. Patients who underwent microsurgery had larger tumors and were younger than those who underwent OBS or GKS. Overall, facial nerve outcomes were satisfactory following treatment, with more than 90% of patients having HB Grade I function at the last clinical follow-up. Treatment was the major risk factor for facial nerve dysfunction. Almost one-fifth of the patients treated with MS had an objective decline in facial nerve function, whereas only 2% in the GKS group and 0% in the OBS cohort had a decline. The physical subscale of the FDI in the VS patients was highly associated with HB grade; however, the social/well-being subscale of the FDI was not. Thus, any social disability caused by facial palsy was not detectable by use of this questionnaire.CONCLUSIONSThe majority of patients with small- and medium-sized VSs attain excellent long-term facial nerve function and low facial nerve disability regardless of treatment modality. Tumor size and microsurgical treatment are risk factors for facial nerve dysfunction and self-reported disability. The FDI questionnaire is sensitive to the physical but not the social impairment associated with facial dysfunction.
Vascularized appendicular lymph node transfer for treatment of extremity lymphedema: A case report
Ciudad, Pedro , Manrique, Oscar J. , Date, Shivprasad , Chang, Wei‐Ling , Nicoli, Fabio , Sapountzis, Stamatis , Cheng, Hsu‐Tang , Agko, Mouchammed , Chen, Hung‐Chi , Roberts, Lewis R. , Chen, Hung‐Chi , Roberts, Lewis R , Cheng, Hsu-Tang , Mouchammed, Agko

Microsurgery | December 2, 2016 | Volume: 38 | Issue: 5 | Pages: 553-557

10.1002/micr.30134 | PMID 27911477 Get It

AbstractVascularized lymph node transfer has demonstrated promising results for the treatment of extremity lymphedema. In an attempt to find the ideal donor site, several vascularized lymph nodes have been described. Each has a common goal of decreasing morbidity and avoiding iatrogenic lymphedema while obtaining good clinical results. Herein, we present the preliminary clinical outcomes of an intra‐abdominal lymph node flap option based on the appendicular artery and vein used for the treatment of extremity lymphedema. A 62 year‐old woman with moderate lower extremity lymphedema, on chronic antibiotics because of recurrent infections and unsatisfactory outcomes after conservative treatment underwent a vascularized appendicular lymph node (VALN) transfer. At a follow‐up of 6 months, the reduction rate of the limb circumference was 17.4%, 15.1%, 12.0% and 9% above the knee, below the knee, above the ankle and foot respectively. In addition, no further episodes of infection or other complications were reported after VALN transfer. Postoperative lymphoscintigraphy demonstrated that the VALN flap was able to improve the lymphatic drainage of the affected limb. According to our findings, the use of VALN transfer minimizes donor‐site morbidity, avoids iatrogenic lymphedema and may provide a strong clearance of infection because of the strong immunologic properties of the appendiceal lymphatic tissue in selected patients. Despite these promising results, further research with larger number of patients and longer follow‐ up is needed.
Chapter 5 Ethical Considerations in the Use of Deep Brain Stimulation
Fiksdal, Alexander , Abulseoud, Osama A. , Sharp, Richard R.

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 85-98

10.1201/9781315364759-6 Get It

Chapter 2 Biophysical Fundamentals of Neural Excitation
Löffler, Susanne , Luján, J. Luis

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 25-50

10.1201/9781315364759-3 Get It

Chapter 21 Closed-Loop Control Systems for Deep Brain Stimulation Therapy
Trevathan, James K. , Luján, J. Luis , Trevathan, James K

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 389-414

10.1201/9781315364759-22 Get It

Chapter 18 The Role of Astrocytes in Deep Brain Stimulation
Chang, Su-Youne , Lee, Kendall H.

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 339-356

10.1201/9781315364759-19 Get It

Chapter 16 Functional Electrical Stimulation for the Treatment of Spinal Cord Injury
Grahn, Peter J. , Ruiz, Aldo A. Mendez, Ruiz, Aldo A. Mendez, Hachmann, Jan T. , Luján, J. Luis

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 283-310

10.1201/9781315364759-17 Get It

Chapter 14 Deep Brain Stimulation for Memory Dysfunction
Ross, Erika K., Ross, Erika K., Bieniek, Kevin F. , Min, Hoon-Ki Paul

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 257-274

10.1201/9781315364759-15 Get It

Chapter 11 Deep Brain Stimulation for Treatment-Resistant Depression
Kim, Yesul , Wininger, Katheryn M. , Tye, Susannah J.

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 197-214

10.1201/9781315364759-12 Get It

Chapter 9 Deep Brain Stimulation for Obsessive-Compulsive Disorder
Gaba, Prakriti , Blaha, Charles D.

Deep Brain Stimulation | December 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: 163-180

10.1201/9781315364759-10 Get It